If you are a healthy older adult age 65 to 85 with normal memory, now is the time to join the fight to prevent Alzheimer’s disease. The A4 Study is a landmark clinical trial that is testing a new drug that may help slow memory loss associated with Alzheimer’s disease. Read more about A4.
Research is taking place at 56 U.S. sites, as well as four sites in Canada and one in Australia.
People who do not qualify for the main A4 study may be asked to participate in a separate study, in which they will take memory tests every 6 months.
Watch the A4 video:
The A4 Study is a landmark public-private partnership, funded by the National Institutes of Health, Eli Lilly and Company, and several philanthropic organizations. It is coordinated by the Alzheimer’s Disease Cooperative Study, located at the University of California, San Diego.
A4 flyer (PDF, 591K)
A4 brochure (PDF, 1.7M)